v3.26.1
SEGMENT INFORMATION
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
SEGMENT INFORMATION SEGMENT INFORMATION
In the second quarter of 2026, we made a strategic change to our executive leadership and to our segments, combining our Imaging and AVS businesses into a new operating and reportable segment, Advanced Imaging Solutions. The AIS segment has a product portfolio that serves customers across three core areas: Radiology, Specialized Ultrasound, and Procedural Guidance. Radiology was formerly reported as our Imaging business, while Specialized Ultrasound and Procedural Guidance were previously reported in our AVS business. Historical segment financial information presented within this report has been recast to conform to the new reportable segment structure.

Following this organizational change, the Company has three reportable segments: AIS, PDx, and PCS. These segments have been identified based on the nature of the products sold and how the Company manages its operations. We have not aggregated any of our operating segments to form reportable segments.

The Company’s organizational structure is based upon the availability of separate financial information that is evaluated regularly by the Company’s CODM for the purpose of assessing performance and allocating resources. The Company’s CODM is our Chief Executive Officer. The CODM assesses segment performance using Total revenues and an earnings metric defined as “Segment EBIT.” Segment EBIT is calculated as Income before income taxes in our Condensed Consolidated Statements of Income excluding the impact of the following: Interest and other financial charges – net, Non-operating benefit (income) costs, restructuring costs, acquisition and disposition-related benefits (charges), gain (loss) on business and asset dispositions, Spin-Off and separation costs and other adjustments, amortization of acquisition-related intangible assets, investment revaluation gain (loss), and other non-recurring items such as refunds for tariffs incurred in prior years. Segment EBIT is also used in the annual budget and periodic forecasting processes and informs the CODM in decision making regarding the allocation of resources to the segments.

Total Revenues by Segment
For the three months ended June 30
For the six months ended June 30
2026
2025
2026
2025
AIS:
Radiology
$
2,388 
$
2,204 
$
4,686 
$
4,344 
Procedural Guidance
715 
660 
1,434 
1,301 
Specialized Ultrasound
668 
630 
1,290 
1,228 
Total AIS
3,771 
3,493 
7,410 
6,872 
Total PDx
843 
729 
1,612 
1,362 
PCS:
Monitoring Solutions
503 
578 
1,022 
1,135 
Life Support Solutions
172 
200 
357 
397 
Total PCS
675 
778 
1,379 
1,531 
Other(1)
6 
6 
24 
19 
Total revenues
$
5,295 
$
5,007 
$
10,425 
$
9,784 
(1) Financial information not presented within the reportable segments, shown within the Other category, represents HealthCare Financial Services (“HFS”), which does not meet the definition of an operating segment.

Significant Expenses by Segment
For the three months ended June 30
For the six months ended June 30
2026
2025
2026
2025
AIS:
Cost of sales
$
2,254 
$
2,106 
$
4,458 
$
4,057 
Other segment items(1)
992 
932 
1,948 
1,901 
Total AIS
$
3,246 
$
3,039 
$
6,407 
$
5,958 
PDx:
Cost of sales
$
422 
$
371 
$
828 
$
666 
Other segment items(1)
171 
144 
338 
278 
Total PDx
$
593 
$
516 
$
1,166 
$
943 
PCS:
Cost of sales
$
494 
$
507 
$
975 
$
988 
Other segment items(1)
207 
212 
420 
436 
Total PCS
$
700 
$
719 
$
1,395 
$
1,423 
(1) Other segment items for each segment includes selling, general, administrative, research, and development related expenses, as well as other segment income and expenses.
Segment EBIT
For the three months ended June 30
For the six months ended June 30
2026
2025
2026
2025
Segment EBIT
AIS
$
525 
$
455 
$
1,004 
$
914 
PDx
250 
213 
446 
418 
PCS
(26)
60 
(16)
108 
Other(1)
1 
1 
6 
3 
750 
729 
1,440 
1,443 
Restructuring costs
(27)
(18)
(76)
(40)
Acquisition and disposition-related benefits (charges)
(11)
(7)
(46)
(15)
Gain (loss) on business and asset dispositions
— 
(5)
— 
5 
Spin-Off and separation costs and other adjustments
5 
(5)
2 
(29)
Amortization of acquisition-related intangible assets
(61)
(40)
(108)
(75)
Investment revaluation gain (loss)
— 
(1)
(8)
92 
Interest and other financial charges – net
(114)
(113)
(210)
(224)
Non-operating benefit income (costs)
45 
73 
96 
148 
Tariff refunds
106 
— 
106 
— 
Income before income taxes
$
693 
$
613 
$
1,198 
$
1,304 
(1) Financial information not presented within the reportable segments, shown within the Other category, primarily represents HFS, which does not meet the definition of an operating segment.

The following table represents the depreciation and amortization amounts reported within the Segment EBIT metric for our reportable segments. Depreciation and amortization expense related to shared property, plant, and equipment and intangibles, exclusive of acquisition-related intangible assets, has been fully allocated to our segments and those allocations are reflected in the amounts presented in the table below. These amounts are included within Cost of sales and Other segment items disclosed in the Significant Expenses by Segment table above.

Depreciation and Amortization by Segment
For the three months ended June 30
For the six months ended June 30
2026
2025
2026
2025
AIS
$
67 
$
75 
$
139 
$
151 
PDx
19 
17 
39 
29 
PCS
13 
13 
25 
27 

The Company does not report total assets by segment as the Company’s CODM does not assess performance, make strategic decisions, or allocate resources based on assets.